---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-25-000818"
form_type: "8-K"
ticker: "ZEOX"
cik: "0001557376"
company_name: "Zeo ScientifiX, Inc."
filed_at: "2025-02-10T23:59:59+00:00"
generated_at: "2026-05-27T00:01:12.857621+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Zeo ScientifiX enters joint development MOU with BioXtek, appoints Dr. Peter Everts as CSO

## Summary
- Binding MOU with BioXtek for joint development, manufacturing, marketing, and funding arrangement.
- ZEO to relocate to BioXtek's 11,000 sq ft Pompano Beach facility by May 31, 2025.
- Parties to form 50/50 SPE to pursue FDA BLA approval for membrane products.
- Dr. Peter Everts appointed CSO; salary $220K first year, option for 25,000 shares at $3.05.
- Severance: 1/4 month salary per 3 months after 90-day initial period.

## SEC filing metadata
- accession: 0001829126-25-000818
- form_type: 8-K
- ticker: ZEOX
- cik: 0001557376
- company_name: Zeo ScientifiX, Inc.
- filed_at: 2025-02-10T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1557376/000182912625000818/0001829126-25-000818-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1557376/000182912625000818/zeoscientifix_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-25-000818
- JSON: https://secwatch.observer/filing/0001829126-25-000818.json
- Plain text: https://secwatch.observer/filing/0001829126-25-000818.txt

## Key facts
- Executive change
  Dr. Peter A. M. Everts was appointed as Chief Scientific and Technology Officer at Zeo ScientifiX, Inc..
  - Action: appointed
  - Role: Chief Scientific and Technology Officer
  source text: Effective February 7, 2025, Dr. Peter A. M. Everts, Ph.D. (“ Dr. Everts” ) was appointed the Company’s Chief Scientific and Technology Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1557376/000182912625000818/0001829126-25-000818-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.